Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor

Authors: Santhosh A Upadhyaya, Olivia Campagne, Catherine A Billups, Brent A Orr, Arzu Onar-Thomas, Ruth G Tatevossian, Roya Mostafavi, Jason R Myers, Anna Vinitsky, Daniel C Moreira, Holly B Lindsay, Lindsay Kilburn, Patricia Baxter, Amy Smith, John R Crawford, Sonia Partap, Anne E Bendel, Dolly G Aguilera, Kim E Nichols, Evadnie Rampersaud, David W Ellison, Paul Klimo, Zoltan Patay, Giles W Robinson, Alberto Broniscer, Clinton F Stewart, Cynthia Wetmore, Amar Gajjar

Published: 2022-06-02

DOI: 10.1093/neuonc/noac151

Source: Full article


Abstract

Abstract